Morgan Stanley’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.23M Sell
1,162,320
-414,093
-26% -$2.44M ﹤0.01% 3969
2026
Q1
$6.97M Sell
1,576,413
-133,370
-8% -$789K ﹤0.01% 3874
2025
Q4
$9.15M Buy
1,709,783
+1,270,030
+289% +$10.1M ﹤0.01% 3683
2025
Q3
$4.23M Sell
439,753
-11,576
-3% -$107K ﹤0.01% 4283
2025
Q2
$3.32M Buy
451,329
+188,866
+72% +$1.27M ﹤0.01% 4382
2025
Q1
$1.23M Sell
262,463
-53,077
-17% -$265K ﹤0.01% 4909
2024
Q4
$1.43M Buy
315,540
+76,880
+32% +$409K ﹤0.01% 4910
2024
Q3
$663K Buy
238,660
+107,943
+83% +$287K ﹤0.01% 5265
2024
Q2
$400K Buy
130,717
+57,390
+78% +$221K ﹤0.01% 5389
2024
Q1
$303K Buy
+73,327
New +$226K ﹤0.01% 5553

Other funds holding ASPI

Morgan Stanley's ASPI Position: Q2 2026 in Review

Morgan Stanley reduced its ASP Isotopes (ASPI) stake by 26% in Q2 2026, selling an estimated $2.44M and leaving 1,162,320 shares worth $7.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3969.

Morgan Stanley first reported a position in ASPI in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.15M in Q4 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.

  • Morgan Stanley held 1,162,320 shares of ASP Isotopes worth $7.23M as of Q2 2026.
  • Morgan Stanley sold 414,093 ASP Isotopes shares in Q2 2026, an estimated $2.44M.
  • ASP Isotopes made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3969 holding.
  • Morgan Stanley first reported a position in ASP Isotopes in Q1 2024 and has held it in 10 quarters since.
  • Morgan Stanley's ASP Isotopes position peaked at $9.15M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.